v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Jul. 28, 2012
Jul. 30, 2011
Jul. 31, 2010
Cash flows from operating activities:      
Net income $ 162.2 $ 170.5 $ 133.4
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 107.4 89.8 71.6
Deferred income tax expense (benefit) (5.3) 16.9 14.7
Deferred rent and other occupancy costs (24.6) (24.2) (18.1)
Loss on extinguishment of debt (Note 14)   4.0 5.8
Loss (gain) on sale of assets (8.2) 2.5  
Non-cash stock-based compensation expense 28.4 19.7 10.0
Non-cash impairments of assets 2.2 4.6 10.7
Non-cash interest expense 0.9 2.8 4.0
Other non-cash expense (11.0) (4.7) (3.8)
Excess tax benefits from stock-based compensation (11.7) (5.7) (5.8)
Changes in operating assets and liabilities:      
Inventories 26.5 (45.1) (10.2)
Accounts payable and accrued liabilities (18.3) 17.9 7.2
Deferred income liabilities 2.9 8.3 4.7
Lease-related liabilities 27.9 14.5 7.7
Other balance sheet changes 44.4 9.0 (0.5)
Changes in net assets related to discontinued operations 37.8    
Net cash provided by operating activities 361.5 280.8 231.4
Cash flows from investing activities:      
Purchase price paid in acquisitions, net of cash acquired (Note 5) (683.9)   82.8
Purchases of investments (99.8) (176.0) (78.3)
Proceeds from sales and maturities of investments 293.6 86.0 140.4
Investment in life insurance policies   (5.1) (3.3)
Proceeds from the sale of assets 38.2    
Capital expenditures (150.4) [1] (102.1) [1] (65.2) [1]
Net cash (used in) provided by investing activities (602.3) (197.2) 76.4
Cash flows from financing activities:      
Proceeds from borrowings 322.0    
Repayments of debt (Notes 5 and 14) (144.2) (29.2) (286.7)
Payment of deferred financing costs (7.4) (1.4) (4.4)
Repurchases of common stock (37.2) (72.9) (37.9)
Proceeds from stock options exercised and employee stock purchases 16.7 17.1 15.2
Excess tax benefits from stock-based compensation 11.7 5.7 5.8
Net cash provided by (used in) financing activities 161.6 (80.7) (308.0)
Net increase (decrease) in cash and cash equivalents (79.2) 2.9 (0.2)
Cash and cash equivalents at beginning of period 243.5 240.6 240.8
Cash and cash equivalents at end of period $ 164.3 $ 243.5 $ 240.6
[1] Excludes non-cash capital expenditures of $13.4 million in Fiscal 2012, $3.6 million in Fiscal 2011 and $6.5 million in Fiscal 2010.